Pharma Journalist - Page 49 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Novartis’ Leqvio Achieves Early LDL-C Goals with Less Muscle Pain

Heidelberg Pharma Partner Telix Pharmaceuticals Provides Regulatory Update on Imaging Agent TLX250-CDx

Sandoz Launches Rivaroxaban in Germany, Broadening Access to Antithrombotic Care

IQVIA and Flagship Pioneering Partner to Accelerate Breakthroughs in Life Sciences

Zemcelpro Wins EC Approval as First Cell Therapy for Blood Cancer Patients Without Suitable Donors

Hope Biosciences Earns FDA RMAT Status for Stem Cell Therapy in Relapsing-Remitting MS

RINVOQ Receives Health Canada Approval for Giant Cell Arteritis in Adults

Outlook Therapeutics Issues FDA Review Update on ONS-5010 for Wet AMD

Pfizer and BioNTech’s COMIRNATY Gets FDA Approval for Seniors and High-Risk Individuals Ages 5-64

EU Approves Twice-Yearly Yeytuo (Lenacapavir) for HIV Prevention